Medicamen Biotech Ltd
MEDICAMEQMedicamen Biotech Ltd
MEDICAMEQ![](https://assets.tickertape.in/sector-icons/health_care.png)
![](https://assets.tickertape.in/sector-icons/smallcap.png)
![](https://assets.tickertape.in/sector-icons/high_risk.png)
Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
70.27 | 2.68 | 0.24% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.93 | 6.39 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
MEDICAMEN Biotech is engaged in manufacturing of pharmaceutical formulations.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | — | — | — | 126.26 | 127.44 | 113.47 | 117.17 | 143.33 | 181.63 | 182.94 | ||||||||||
Raw Materials | — | — | — | 81.95 | 80.45 | 68.42 | 55.69 | 81.80 | 157.07 | 161.68 | ||||||||||
Power & Fuel Cost | 2.11 | 2.90 | 2.68 | 5.86 | 5.67 | |||||||||||||||
Employee Cost | 8.09 | 9.52 | 9.00 | 14.50 | 20.15 | |||||||||||||||
Selling & Administrative Expenses | 5.30 | 5.16 | 4.14 | 7.79 | 7.90 | |||||||||||||||
Operating & Other expenses | 7.69 | 8.00 | 8.80 | 7.51 | 1.00 | |||||||||||||||
EBITDA | — | — | — | 21.12 | 21.41 | 20.43 | 25.82 | 26.81 | 24.56 | 21.26 | ||||||||||
Depreciation/Amortization | — | — | — | 2.21 | 2.50 | 2.52 | 5.77 | 6.37 | 7.09 | 7.16 | ||||||||||
PBIT | — | — | — | 18.91 | 18.91 | 17.91 | 20.05 | 20.44 | 17.47 | 14.10 | ||||||||||
Interest & Other Items | — | — | — | 1.38 | 0.93 | 1.51 | 1.94 | 3.39 | 4.40 | 4.16 | ||||||||||
PBT | — | — | — | 17.53 | 17.98 | 16.40 | 18.11 | 17.05 | 13.07 | 9.94 | ||||||||||
Taxes & Other Items | — | — | — | 5.50 | 4.69 | 4.27 | 3.20 | 2.20 | 2.14 | 2.55 | ||||||||||
Net Income | — | — | — | 12.03 | 13.29 | 12.13 | 14.91 | 14.85 | 10.93 | 7.39 | ||||||||||
EPS | — | — | — | 10.28 | 11.11 | 9.93 | 12.20 | 11.94 | 7.50 | 5.84 | ||||||||||
DPS | — | — | — | 1.00 | 0.50 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||||
Payout ratio | — | — | — | 0.10 | 0.04 | 0.10 | 0.08 | 0.08 | 0.13 | 0.17 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Medicamen Biotech Ltd | 47.51 | 2.68 | 0.24% |
Sun Pharmaceutical Industries Ltd | 45.08 | 6.43 | 0.75% |
Cipla Ltd | 31.71 | 4.88 | 0.80% |
Torrent Pharmaceuticals Ltd | 70.18 | 16.95 | 0.82% |
Price Comparison
Compare MEDICAMEQ with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
MEDICAMEQ has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.24%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.44 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
Cash Dividend
Ex DateEx DateSep 18, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Sep 18, 2024
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Sep 20, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateSep 17, 2020
Dividend/Share
₹0.50
Ex DateEx Date
Sep 17, 2020
Cash Dividend
Ex DateEx DateSep 17, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2019
Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Medicamen Biotech’s USFDA filing sparks 5.12 per cent surge in shares
![](https://pocket-image-cache.com/direct?url=http://bl-i.thgim.com/public/incoming/5a4tu4/article67053801.ece/alternates/LANDSCAPE_1200/illicit%20drugs.jpg)
Medicamen Biotech gains on successful ANDA filing for Bortezomib injections
![](https://pocket-image-cache.com/direct?url=http://images.moneycontrol.com/static-mcnews/2023/07/stocks_sensex_nifty_stockmarket-2-770x433.jpg)
Medicamen Biotech announces debut in domestic pharma sector
![](https://assets.tickertape.in/images/news-publishers/iifl.png)
Aarvee Denims & Exports Ltd leads gainers in ‘B’ group
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Medicamen Biotech signs CDMO agreement with Vital Pharma Nordic
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Medi Caps gets approval under RERA for Real Estate Project ‘Medicaps Business Park’
This smallcap pharmaceutical stock has zoomed 62% thus far in December
![](https://pocket-image-cache.com/direct?url=http://bsmedia.business-standard.com/_media/bs/img/article/2017-09/10/full/1505065035-1108.jpg)
Starlit Power Systems Ltd leads gainers in ‘B’ group
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Medicamen Biotech consolidated net profit rises 31.06% in the September 2021 quarter
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 7.54%, vs industry avg of 9.21%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.06% to 0.05%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -1.9%, vs industry avg of 15.17%